But that's about to change, as weight-loss treatments will soon be available in pill form. RELATED: What Really Happens If You Stop Taking Ozempic, Doctors Say. Experimental weight-loss drugs produced as pills are in clinical trials,

Injectable weight loss drugs are popular right now but can be hard to get because they are in short supply or too expensive without insurance. The result is that some people are skipping the doctor's office and reaching out to potentially unreliable sources such as unlicensed online pharmacies or telehealth sites,

Researchers from the University of Liverpool have found that the weight-loss drug tirzepatide could significantly reduce the risk of developing type 2 diabetes (T2D). This finding offers new hope in the battle against obesity and diabetes,

On that note, Terns Pharmaceuticals ( TERN -5.84%) is a biotech developing weight loss therapies that's worth investing $1,000 in today, provided that you're patient enough to hold it for at least a handful of years so that it can (hopefully) get its first product approved for sale. Here's why it's a compelling biotech stock pick.

F ROM LOS ANGELES to London, weight-loss drugs such as Ozempic are reshaping culture as much as waistlines. Some Ozempic-takers have tiny appetites and dine at unusual hours to avoid spells of nausea.

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and Saxenda. Here's what to know.

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable products.

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to set them up with Wegovy, Zepbound and other weight-loss drugs.